PrimeRFP SCOUT · Federal Contract Recompete Brief

75A50325F80038 — AMOXICILLIN TRIHYDRATE 500 MG ORAL CAPSULES 60 AND 100 COUNT BOTTLES

AMOXICILLIN TRIHYDRATE 500 MG ORAL CAPSULES 60 AND 100 COUNT BOTTLES is a federal SBA award for Department of Health and Human Services (HHS) held by ALTITUDE TECHNOLOGIES INC.. Estimated value $47.8M ($47.8M obligated). Current period of performance ends Sep 29, 2027 (potential Sep 29, 2029). Last award drew 3 bidders.

$47.8M
Estimated Value
Sep 29, 2027
PoP End / Expires
3
Bidders (last award)

Track this contract

Get an alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.

See related expiring contracts →

Analysis

Public

ALTITUDE TECHNOLOGIES INC. holds $17.5M across 2,826 federal awards, concentrated at Department of Defense (DOD). Competition previously drew 3 offers. Set-aside status: SBA. Recompete timing centers on the Sep 29, 2027 PoP end — agencies typically plan 12–18 months ahead.

Contract facts

SBA
Contract number75A50325F80038
AgencyDepartment of Health and Human Services (HHS)
IncumbentALTITUDE TECHNOLOGIES INC.
UEIL6NXD48QG5M1
NAICS325412

No full NAICS 325412 intel page yet. Browse NAICS intelligence

PSC6505
Parent IDIQ / IDV36F79725D0059
PoP end (current)Sep 29, 2027
PoP end (w/ options)Sep 29, 2029
Obligated$47.8M

AMOXICILLIN TRIHYDRATE 500 MG ORAL CAPSULES 60 AND 100 COUNT BOTTLES

Recompete timing

Public
Expiring in 408 days

Current PoP ends Sep 29, 2027 (408 days remaining). Agencies typically plan 12–18 months ahead — position before the PoP clock runs out.

Watch this contract — one email →

Incumbent footprint

Public record

ALTITUDE TECHNOLOGIES INC.$17.5M obligated across 2,826 awards (firm-wide, all agencies) · lead buyer Department of Defense (DOD).

% of firm-wide obligated ($17.5M) · all agencies
Department of Defense (DOD)$9.7M · 55%Department of Justice (DOJ)$3.8M · 22%Department of Homeland Security (DHS)$2.3M · 13%Department of Health and Human Services (HHS)$1.6M · 9%
Open full company profile

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP

Track this contract

Get an alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.

More in SCOUT
Track this contract →

Alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.

Size up the competition →

See all live recompete landscapes — who else is expiring, and where the openings are.

Research the incumbent →

Open ALTITUDE TECHNOLOGIES INC.’s federal contract profile — agency mix, recompete pipeline, and teaming relationships.

Frequently asked questions

What is contract 75A50325F80038?

75A50325F80038 (AMOXICILLIN TRIHYDRATE 500 MG ORAL CAPSULES 60 AND 100 COUNT BOTTLES) is a Department of Health and Human Services (HHS) award with an estimated value of $47.8M, currently held by ALTITUDE TECHNOLOGIES INC.. Figures are USASpending-sourced public-record facts normalized by PrimeRFP SCOUT.

Who is the incumbent on 75A50325F80038?

ALTITUDE TECHNOLOGIES INC. is the incumbent with $17.5M across 2826 related awards in SCOUT’s public footprint. The current period of performance ends Sep 29, 2027.

When does 75A50325F80038 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 29, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows. Explore it live — $90 Pilot →

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/36F79725D0059-75A50325F80038